Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Cancer mRNA vaccines: clinical advances and future opportunities
Elias Sayour, David Boczkowski, Duane A. Mitchell, et al.
Nature Reviews Clinical Oncology (2024) Vol. 21, Iss. 7, pp. 489-500
Closed Access | Times Cited: 34

Showing 1-25 of 34 citing articles:

Current and future immunotherapeutic approaches in pancreatic cancer treatment
Pooya Farhangnia, Hossein Khorramdelazad, Hamid Nickho, et al.
Journal of Hematology & Oncology (2024) Vol. 17, Iss. 1
Open Access | Times Cited: 25
Clinical advances of mRNA vaccines for cancer immunotherapy
Alexey V. Yaremenko, Muhammad Muzamil Khan, Xueyan Zhen, et al.
Med (2025) Vol. 6, Iss. 1, pp. 100562-100562
Closed Access | Times Cited: 4
Computational biology and artificial intelligence in mRNA vaccine design for cancer immunotherapy
Saber İmani, Xiaoyan Li, Keyi Chen, et al.
Frontiers in Cellular and Infection Microbiology (2025) Vol. 14
Open Access | Times Cited: 1
Leveraging mRNA technology for antigen based immuno-oncology therapies
Charalampos S. Floudas, Siranush Sarkizova, Michele Ceccarelli, et al.
Journal for ImmunoTherapy of Cancer (2025) Vol. 13, Iss. 1, pp. e010569-e010569
Open Access | Times Cited: 1
Progress and prospects of mRNA-based drugs in pre-clinical and clinical applications
Yingying Shi, Miaoyuan Shi, Yì Wáng, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 5
Tetra-branched ionizable lipids enhance the stability and transfection efficiency of lipid nanoparticles for mRNA delivery
Haoran Xu, Jiaqi Fan, Ji‐Wei Liu, et al.
Chinese Chemical Letters (2025), pp. 110833-110833
Closed Access
Optimization of Conditions for Production of Soluble E. coli Poly(A)-Polymerase for Biotechnological Applications
Igor P. Oscorbin, Maria Sergeyevna Kunova, М. Л. Филипенко
Biology (2025) Vol. 14, Iss. 1, pp. 48-48
Open Access
Cancer Vaccines and Beyond: The Transformative Role of Nanotechnology in Immunotherapy
Violeta Delgado-Almenta, José L. Blaya-Cánovas, Jesús Calahorra, et al.
Pharmaceutics (2025) Vol. 17, Iss. 2, pp. 216-216
Open Access
The Past, Present, and Future of Cervical Cancer Vaccines
Alexander C. Lien, Gertrude C. Johnson, Tianyun Guan, et al.
Vaccines (2025) Vol. 13, Iss. 2, pp. 201-201
Open Access
Adopting tomorrow’s therapies today: a perspective review of adoptive cell therapy in lung cancer
Faith Abodunrin, Daniel J. Olson, Oluwatosin Emehinola, et al.
Therapeutic Advances in Medical Oncology (2025) Vol. 17
Open Access
An mRNA vaccine encoding proteasome-targeted antigen enhances CD8+ T cell immunity
Ling Jin, Hongwei Chen, Mengwen Huang, et al.
Journal of Controlled Release (2025) Vol. 381, pp. 113578-113578
Closed Access
Egfrviii-Driven Microenvironmental Fibroblast Activation and Transformation Accelerate Oral Cancer Progression Via Lipocalin-2/Stat3 Axis
Jang-Yang Chang, Hsuan‐Yu Peng, Kwang Yu Chang, et al.
(2025)
Closed Access
CLINICAL DEVELOPMENT OF IMMUNO-ONCOLOGY THERAPEUTICS
Jianxin Wang, Qi Chen, Qi Shan, et al.
Cancer Letters (2025), pp. 217616-217616
Closed Access
Advancement insights in cancer vaccines: mechanisms, types, and clinical applications
Gellan Alaa Mohamed Kamel, Rasha Attia, Hifaa G. Al-Noman, et al.
Molecular Biology Reports (2025) Vol. 52, Iss. 1
Closed Access
mRNA vaccine platforms: linking infectious disease prevention and cancer immunotherapy
Dariush Haghmorad, Majid Eslami, Niloufar Orooji, et al.
Frontiers in Bioengineering and Biotechnology (2025) Vol. 13
Open Access
Recent Advances and Prospects in RNA Drug Development
Hidenori Tani
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 22, pp. 12284-12284
Open Access | Times Cited: 4
Next-generation combination approaches for immune checkpoint therapy
Sangeeta Goswami, Kristen E. Pauken, Linghua Wang, et al.
Nature Immunology (2024) Vol. 25, Iss. 12, pp. 2186-2199
Closed Access | Times Cited: 4
Cancer vaccines: Target antigens, vaccine platforms and preclinical models
Francesca Ruzzi, Federica Riccardo, Laura Conti, et al.
Molecular Aspects of Medicine (2024) Vol. 101, pp. 101324-101324
Open Access | Times Cited: 3
Vaccine-based immunotherapy and related preclinical models for glioma
Binghao Zhao, Longping Yao, Maryam Hatami, et al.
Trends in Molecular Medicine (2024) Vol. 30, Iss. 10, pp. 965-981
Open Access | Times Cited: 2
Paracyclophane-based ionizable lipids for efficient mRNA delivery in vivo
Shiqi Wu, Kexin Su, Xinxin Yan, et al.
Journal of Controlled Release (2024) Vol. 376, pp. 395-401
Closed Access | Times Cited: 2
The transformative potential of mRNA vaccines for glioblastoma and human cancer: technological advances and translation to clinical trials
Iulia Tapescu, Peter J. Madsen, Pedro R. Löwenstein, et al.
Frontiers in Oncology (2024) Vol. 14
Open Access | Times Cited: 1
Recent Advances and Prospects of Nucleic Acid Therapeutics for Anti-Cancer Therapy
Minhyuk Lee, Min-Jae Lee, Youngseo Song, et al.
Molecules (2024) Vol. 29, Iss. 19, pp. 4737-4737
Open Access | Times Cited: 1
Immune Checkpoint Inhibitors and Vaccination: Assessing Safety, Efficacy, and Synergistic Potential
Jacob New, Luke M. Shenton, Radia Ksayer, et al.
Vaccines (2024) Vol. 12, Iss. 11, pp. 1270-1270
Open Access | Times Cited: 1
Engineering of mRNA vaccine platform with reduced lipids and enhanced efficacy
Tianjiao Ji, Xu Ma, Shaoli Liu, et al.
Research Square (Research Square) (2024)
Open Access
Immunonkologie
Anne Letsch
Deleted Journal (2024) Vol. 30, Iss. 10, pp. 952-958
Closed Access
Page 1 - Next Page

Scroll to top